Diagnosis disclosure of prodromal Alzheimer disease-ethical analysis of two cases

Canadian Journal of Neurological Sciences

Volumn 37, Issue 1, 2010, Pages 67-75

  Porteri, Corinna ^a   Galluzzi, Samantha ^a   Geroldi, Cristina ^a   Frisoni, Giovanni B ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ALZHEIMER DISEASE; ARTICLE; CASE REPORT; CLINICAL PRACTICE; CLINICAL RESEARCH; FEMALE; HUMAN; MEDICAL ETHICS; NEUROLOGIC DISEASE; NEUROPSYCHOLOGICAL TEST; PATIENT ATTITUDE; PATIENT AUTONOMY; PRIORITY JOURNAL; SOCIAL BEHAVIOR;

EID: 76649106432     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100009677     Document Type: Article

References (31)

1. Dubois B, Feldman HH, Jacova C, DeKosky ST, Barberger-Gateau P, Cummings J, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol. 2007;6:734-746
2. Frisoni GB, Prestia A, Zanetti O, Galluzzi S, Romano M, Cotelli M, et al. Markers of Alzheimer's disease in a population attending a memory clinic. Alzheimers Dement. 2009;5(4):307-317
3. Frisoni GB, Galluzzi S, Signorini M, Garibotto V, Paghera B, Binetti G, et al. Preliminary evidence of validity of the revised criteria for Alzheimer's disease diagnosis; report of two cases. Alzheimer Dis Assoc Disord. 2009 Jun29. [Epub ahead of print].
4. Alzheimer's Association [homepage on the Internet]. Chicago [updated 2009 Jul 16; cited 2009 Jul 17]. Available from: http://www.alz.org/index.asp.
5. Diagnostic disclosure. [updated 2007 Jan 6]. Available from:http://www.alz.org/professionals- and-researchers-diagnostic-disclosure. asp;
6. Partnering with your doctor: A guide for persons with memory problems and their caregivers, 2003. Available from: http://www.alz.org/ national/documents/brochure-partneringwithyourdoctor.pdf;
7. Telling others about an Alzheimer diagnosis, 2007 Sep. Available from: http://www.alz.org/national/documents/ topicsheet-tell diagnosis.pdf.
8. Bamford C, Lamont S, Eccels M, Robinson L, May C, Bond J. Disclosing the diagnosis of dementia: a systematic review. Int J Geriatr Psychiatry. 2004;19:151-169
9. Kaduszkiewicz H, Bachmann C, van den Bussche H. Telling "the truth" in dementia - Do attitude and approach of general practitioners and specialists differ? Patient Educ Couns. 2008; 70:220-226
10. Tarek ME, Segers K, Van Nechel C. What Belgian neurologists and neuropsychiatrists tell their patients with Alzheimer disease and why. A national survey. Alzheimer Dis Assoc Disord. 2009;23: 33-37
11. Margiotta A, Iacono S, D'Autilia N, Luberto S, Pinelli M, Baldelli MV, et al. Diagnostic, therapeutic, ethic and legal issues in caring for dementia: the viewpoint of medical representative in Modena (Italy). Arch Gerontol Geriatr. 2002; Suppl.8:191-198
12. Pucci E, Belardinelli N, Borsetti G, Giuliani G. Relatives' attitudes towards informing patients about the diagnosis of Alzheimer's disease. J Med Ethics. 2003;29:51-54
13. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease -report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984; 34:939-44.
14. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (IV-TR), 4th edn-text revised. Washington, DC: 2000.
15. Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, et al. Atrophy of medial temporal lobes on MRI in"probable"Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55:967-972
16. Sjögren M, Vanderstichele H, Agren H, Zachrisson O, Edsbagge M, Wikkelsø C, et al. Tau and Abeta42 in cerebrospinal fluid from healthy adults 21-93 years of age: establishment of reference values. Clin Chem. 2001;47:1776-1781
17. Riello R, Sabattoli F, Beltramello A, Bonetti M, Bono G, Falini A, et al. Brain volumes in healthy adults aged 40 years and over: a voxel-based morphometry study. Aging Clin Exp Res. 2005;17: 329-336
18. Prestia A, Rossi R, Geroldi C, Galluzzi S, Ettori M, Alaimo G, et al. Validation study of the three-objects-three-places test: a screening test for Alzheimer's disease. Exp Aging Res. 2006;32: 395-410.
19. Spinnler H, Tognoni G. Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci. 1987;6(Suppl 8):1-120.
20. Caffarra P, Vezzadini G, Dieci F, Zonato F, Venneri A. Rey- Osterrieth complex figure: normative values in an Italian population sample. Neurol Sci. 2002;22:443-447
21. Wechsler D. Wechsler Adult Intelligence Scale. 3rd ed. San Antonio, TX: Psychological Corp. 1997.
22. Novelli G, Papagno C, Capitani E, Laiacona M, Vallar G, Cappa SF. Tre test clinici di ricerca e produzione lessicale. Taratura su soggetti normali. Archivio di Psicologia, Neurologia e Psichiatria. 1986;47:477-505.
23. Caselli RJ, Chen K, LeeW, Alexander GE, Reiman EM. Correlating cerebral hypometabolism with future memory decline in subsequent converters to amnestic pre-mild cognitive impairment. Arch Neurol. 2008;65:1231-1236
24. Hansson O, Zetterberg H, Buchhave P, Londos E, Blennow K, Minthon L. Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study. Lancet Neurol. 2006;5:228-234
25. Jack CR, Petersen RC, Xu YC, O'Brien PC, Smith GE, Ivnik RJ, et al. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999; 52:1397-1403
26. Frisoni GB, Padovani A, Wahlund LO. The predementia diagnosis of Alzheimer disease. Alzheimer Dis Assoc Disord. 2004;18: 51-53
27. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Systematic Reviews 2006, Issue 1. Art. No.: CD005593. DOI: 10.1002/14651858.CD005593.
28. Clare L, Woods B. Cognitive rehabilitation and cognitive training for early-stage Alzheimer's disease and vascular dementia. Cochrane Database of Systematic Reviews 2003, Issue 4. Art. No.: CD003260. DOI: 10.1002/14651858. CD003260.
29. Salloway S, Ferris S, Kluger A, Goldman R, Griesing T, Kumar D, et al. Efficacy of donepezil in mild cognitive impairment: a randomized placebo-controlled trial. Neurology. 2004;63(4): 651-657
30. Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, et al. Vitamin E and donepezil for the treatment of mild cognitive impairment. N Engl J Med. 2005;352(23):2379-2388
31. Feldman HH, Ferris S, Winblad B, Sfikas N, Mancione L, He Y, et al. Effect of rivastigmine on delay to diagnosis of Alzheimer's disease from mild cognitive impairment: the InDDEx study. Lancet Neurol. 2007;6(6):501-512